Bristol Myers Squibb Co has expressed interest in buying autoimmune disease drug developer Aurinia Pharmaceuticals Inc , Bloomberg News reported on Friday, citing people familiar with the matter.
Aurinia's shares closed up nearly 27% on the news, giving it a market capitalization of $3.59 billion, according to Refinitiv data.
The report said no final decision has been made and that Bristol Myers could opt out of a potential deal.Aurinia sells a treatment for a kidney disorder called lupus nephritis and is testing out treatments for other autoimmune and kidney diseases, according to its website.More from ReutersSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
The Hairy Bikers' Dave Myers and Si King's health scares led to 6st weight loss – see photos, plus how they did itDave Myers and Si King weight loss: see how The Hairy Bikers lost weight after serious health scares.
Les mer »
UTA Chief’s Zinger: We’re Too Profitable For Endeavor to Buy UsAsked about Endeavor CEO Ari Emanuel's comment that his company wasn't interested in buying UTA, Jeremy Zimmer said Thursday 'we wouldn't fit in.'
Les mer »
The Mythical Million Dollar Wu-Tang Album Has a New OwnerThe NFT collecting collective, PleasrDAO, has acquired the single copy Wu-Tang Clan album, Once Upon a Time in Shaolin, after it was auctioned off by the US government.
Les mer »
WSJ News Exclusive | Blackstone Buying Majority Stake in SpanxThe deal values Spanx at $1.2 billion. Spanx founder Sara Blakely will maintain a significant stake in the company and continue to oversee operations.
Les mer »
The Hairy Bikers' Dave Myers and Si King's health scares led to 6st weight loss – see photos, plus how they did itDave Myers and Si King weight loss: see how The Hairy Bikers lost weight after serious health scares.
Les mer »